NZ591181A - Organoarsenic compounds and methods for the treatment of cancer - Google Patents
Organoarsenic compounds and methods for the treatment of cancerInfo
- Publication number
- NZ591181A NZ591181A NZ591181A NZ59118109A NZ591181A NZ 591181 A NZ591181 A NZ 591181A NZ 591181 A NZ591181 A NZ 591181A NZ 59118109 A NZ59118109 A NZ 59118109A NZ 591181 A NZ591181 A NZ 591181A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cancer
- treatment
- methods
- lymphoma
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 208000027190 Peripheral T-cell lymphomas Diseases 0.000 abstract 2
- 208000031672 T-Cell Peripheral Lymphoma Diseases 0.000 abstract 2
- 208000020968 mature T-cell and NK-cell non-Hodgkin lymphoma Diseases 0.000 abstract 2
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 201000007924 marginal zone B-cell lymphoma Diseases 0.000 abstract 1
- 208000021937 marginal zone lymphoma Diseases 0.000 abstract 1
- 208000025275 nodular sclerosis classical Hodgkin lymphoma Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18951108P | 2008-08-20 | 2008-08-20 | |
| PCT/US2009/053858 WO2010021928A1 (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ591181A true NZ591181A (en) | 2012-09-28 |
Family
ID=41707414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ591181A NZ591181A (en) | 2008-08-20 | 2009-08-14 | Organoarsenic compounds and methods for the treatment of cancer |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US20110269697A1 (enExample) |
| EP (2) | EP3388111B1 (enExample) |
| JP (5) | JP5933896B2 (enExample) |
| KR (3) | KR20110058818A (enExample) |
| CN (2) | CN102149432A (enExample) |
| AU (1) | AU2009282972A1 (enExample) |
| BR (1) | BRPI0918407A2 (enExample) |
| CA (1) | CA2734650A1 (enExample) |
| DK (2) | DK3388111T3 (enExample) |
| ES (2) | ES2901426T3 (enExample) |
| HK (1) | HK1212218A1 (enExample) |
| IL (1) | IL211153A0 (enExample) |
| MX (1) | MX2011001800A (enExample) |
| NZ (1) | NZ591181A (enExample) |
| PT (2) | PT2321012T (enExample) |
| RU (1) | RU2534606C2 (enExample) |
| SG (3) | SG10201810450QA (enExample) |
| WO (1) | WO2010021928A1 (enExample) |
| ZA (1) | ZA201101216B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI617305B (zh) * | 2013-12-05 | 2018-03-11 | 蘇愛康制藥有限公司 | 治療癌症的化合物及其應用程序 |
| CN104151397A (zh) * | 2014-07-03 | 2014-11-19 | 北京大学 | 一类新型三硫杂二环有机砷化物及其合成方法和在抗肿瘤领域里的应用 |
| JP6413969B2 (ja) * | 2015-07-29 | 2018-10-31 | 住友金属鉱山株式会社 | 日射遮蔽体形成用分散液および当該分散液を用いた日射遮蔽体 |
| WO2019220961A1 (ja) * | 2018-05-18 | 2019-11-21 | ソレイジア・ファーマ株式会社 | ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤 |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| CN113408945B (zh) * | 2021-07-15 | 2023-03-24 | 广西中烟工业有限责任公司 | 一种烤烟纯度的检测方法、装置、电子设备及存储介质 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US234972A (en) | 1880-11-30 | William ennis | ||
| US761900A (en) | 1904-03-05 | 1904-06-07 | Newton Jefferson Norman | Flux compound. |
| US2349729A (en) | 1940-08-24 | 1944-05-23 | Parke Davis & Co | Therapeutic arsenic preparation |
| WO1999018798A1 (en) | 1997-10-15 | 1999-04-22 | Polarx Biopharmaceuticals, Inc. | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| IL136051A0 (en) | 1997-11-10 | 2001-05-20 | Sloan Kettering Inst Cancer | Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| CN1233476A (zh) | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| CN1443064A (zh) | 2000-04-26 | 2003-09-17 | 俄勒冈健康科学大学 | 施用含硫醇化学保护化合物的方法 |
| DE10132625A1 (de) | 2001-07-05 | 2003-01-23 | Oce Printing Systems Gmbh | Verfahren, Computerprogrammprodukt und Gerätesystem zum visuellen Überprüfen von Bilddaten |
| EP2462932A1 (en) | 2002-01-07 | 2012-06-13 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TW201440760A (zh) * | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| ES2532666T3 (es) | 2005-07-29 | 2015-03-30 | Solasia Pharma K.K. | Compuestos y métodos para el tratamiento del cáncer |
| CN104109177A (zh) * | 2006-01-13 | 2014-10-22 | 得克萨斯州A&M大学系统 | 用于治疗癌症的化合物和方法 |
| TW200829261A (en) | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| CA2694983A1 (en) * | 2007-07-17 | 2009-01-22 | Combinatorx, Incorporated | Treatments of b-cell proliferative disorders |
| CA2694987A1 (en) * | 2007-07-17 | 2009-01-22 | Combinatorx, Incorporated | Combinations for the treatment of b-cell proliferative disorders |
| KR20100100835A (ko) * | 2007-11-02 | 2010-09-15 | 지오팜 온콜로지 인코포레이티드 | 유기 비소제와의 병용 요법 |
| WO2009151569A2 (en) * | 2008-06-09 | 2009-12-17 | Combinatorx, Incorporated | Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
-
2009
- 2009-08-14 RU RU2011110392/14A patent/RU2534606C2/ru active
- 2009-08-14 PT PT09808635T patent/PT2321012T/pt unknown
- 2009-08-14 KR KR1020117006250A patent/KR20110058818A/ko not_active Ceased
- 2009-08-14 KR KR1020177024240A patent/KR20170103023A/ko not_active Ceased
- 2009-08-14 JP JP2011523888A patent/JP5933896B2/ja active Active
- 2009-08-14 AU AU2009282972A patent/AU2009282972A1/en not_active Abandoned
- 2009-08-14 WO PCT/US2009/053858 patent/WO2010021928A1/en not_active Ceased
- 2009-08-14 ES ES18174817T patent/ES2901426T3/es active Active
- 2009-08-14 MX MX2011001800A patent/MX2011001800A/es not_active Application Discontinuation
- 2009-08-14 SG SG10201810450QA patent/SG10201810450QA/en unknown
- 2009-08-14 CN CN2009801356542A patent/CN102149432A/zh active Pending
- 2009-08-14 SG SG10201810449XA patent/SG10201810449XA/en unknown
- 2009-08-14 NZ NZ591181A patent/NZ591181A/xx not_active IP Right Cessation
- 2009-08-14 EP EP18174817.9A patent/EP3388111B1/en active Active
- 2009-08-14 PT PT181748179T patent/PT3388111T/pt unknown
- 2009-08-14 ES ES09808635T patent/ES2703740T3/es active Active
- 2009-08-14 CN CN201410740427.5A patent/CN104800828A/zh active Pending
- 2009-08-14 EP EP09808635.8A patent/EP2321012B1/en active Active
- 2009-08-14 DK DK18174817.9T patent/DK3388111T3/da active
- 2009-08-14 CA CA2734650A patent/CA2734650A1/en not_active Abandoned
- 2009-08-14 US US13/059,176 patent/US20110269697A1/en not_active Abandoned
- 2009-08-14 SG SG10201403869TA patent/SG10201403869TA/en unknown
- 2009-08-14 BR BRPI0918407A patent/BRPI0918407A2/pt not_active Application Discontinuation
- 2009-08-14 KR KR1020187026317A patent/KR20180103194A/ko not_active Ceased
- 2009-08-14 DK DK09808635.8T patent/DK2321012T3/en active
-
2011
- 2011-02-10 IL IL211153A patent/IL211153A0/en unknown
- 2011-02-15 ZA ZA2011/01216A patent/ZA201101216B/en unknown
-
2014
- 2014-05-26 JP JP2014108079A patent/JP5976036B2/ja active Active
- 2014-10-27 US US14/524,586 patent/US10842769B2/en active Active
-
2015
- 2015-03-30 JP JP2015068284A patent/JP2015120755A/ja not_active Withdrawn
-
2016
- 2016-01-07 HK HK16100117.0A patent/HK1212218A1/xx unknown
- 2016-09-29 JP JP2016191062A patent/JP6315841B2/ja active Active
-
2017
- 2017-12-19 JP JP2017242759A patent/JP2018039853A/ja active Pending
-
2020
- 2020-10-15 US US17/071,623 patent/US11324714B2/en active Active
- 2020-10-15 US US17/071,435 patent/US11324713B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010004074A (es) | Combinacion 059. | |
| MXPA05009694A (es) | Metodos para mejorar la calidad de la piel. | |
| NZ591181A (en) | Organoarsenic compounds and methods for the treatment of cancer | |
| ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
| TW200744586A (en) | Therapeutic compounds | |
| GB0318447D0 (en) | Therapeutic agents | |
| BRPI0507984A (pt) | composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamìfero, para melhorar a resistência de insulina em um mamìfero e para prevenir ou tratar doenças circulatórias em um mamìfero, e, uso do composto | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| PT1613315E (pt) | Derivados da quinolina-2-ona para o tratamento de doenças das vias aéreas respiratórias | |
| NZ545935A (en) | Method of treating cancer with HDAC inhibitors | |
| SG148177A1 (en) | Novel cis-imidazolines | |
| MX2009005649A (es) | Tratamiento para mieloma multiple. | |
| EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
| UA96777C2 (ru) | Фенилпропионамидные соединения и их применение как опиоидных агонистов | |
| GB0207495D0 (en) | Organic compounds | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| TW200602030A (en) | Use of loteprednol etabonate for the treatment of dry eye | |
| ATE401087T1 (de) | Verbindungen zur schmerzbehandlung | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| GB0416508D0 (en) | Therapeutic agents | |
| MY183063A (en) | Seed treatment agent and method for protecting plant | |
| GB2426517A (en) | Methods and agents for inhibiting dynamin-dependent endocytosis | |
| MX2011012538A (es) | Terapia de combinacion para el tratamiento del mieloma multiple. | |
| DE60325965D1 (de) | Für die behandlung bzw. prevention von schmerzen geeignete triazaspiroverbindungen | |
| PL1648473T3 (pl) | Pojedyncza dawka szybko rozpuszczającej się azytromycyny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 14 AUG 2016 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20130504 |
|
| LAPS | Patent lapsed |